Article Details

AstraZeneca's (AZN) Overweight Rating Reaffirmed at Barclays - ETF Daily News

Retrieved on: 2022-01-25 16:57:28

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's (AZN) Overweight Rating Reaffirmed at Barclays - ETF Daily News. View article details on HISWAI: https://etfdailynews.com/news/astrazenecas-azn-overweight-rating-reaffirmed-at-barclays/

Excerpt

AstraZeneca PLC logo Barclays reaffirmed their overweight rating on shares of AstraZeneca (LON:AZN) in a research note issued to investors on ...

Article found on: etfdailynews.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up